About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

WITHDRAWNNANCT04255329

Non Verbal Communication and Dementia

Cognitive impairements in Alzheimer's and apparented disorders may lead to the decreased engagement in activities, spetially in moderate and advanced stages of evolution. The lack of stimulation for p...

Lead sponsor: University Hospital, Montpellier•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Montpellier

Collaborators

University of Geneva, Switzerland

Age

65 - 100 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•65 years and more
•Diagnosed with Alzheimer's disease and/or related disease (frontotemporal dementia, vascular dementia, multiple etiologies dementia, Lewy's Body dementia) according to DSM-IV-TR criteria (2005)
•MMSE ≤ 15
•Good reading ability assessed using Montessori Reading Test (ability to read text written in Arial 40)
•The written agreement of the patient, primary caregiver or curator or or guardian to participate in the study and to make a film about the participant.
•Patient receiving social security benefits

Exclusion Criteria

•Previously known associated psychotic disorder
•Deafness not compensated by hearing aid
•Extrapyramidal syndrome diagnosed by a practitioner
•Tendency to daytime sleepiness (Score 6 on the Karolinska somnolence scale)
•Patient with disruptive behaviour disorders such as screaming and/or motor agitation likely to affect the smooth running of the workshop
•Subject deprived of liberty by judicial or administrative decision.
•Subject under exclusion for another research protocol.
•Presence of motor stereotypes
•Patient receiving State Medical Assistance (AME)
•Patient under Justice Safeguard
•If the patient or guardian cannot be given informed information

Related studies

RECRUITINGPhase 3

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

NCT07571161 · Alzheimer Disease

RECRUITINGPhase 2

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

NCT06847321 · Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis

RECRUITINGPhase 3

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT06937229 · Alzheimer Disease, Agitation

RECRUITINGPhase 4

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

NCT07633470 · Alzheimer Disease

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

NCT04579120 · Alzheimer Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 30, 2021Terms

Trial snapshot

StatusWITHDRAWN

PhaseNA

Enrollment—

Start dateFeb 2020

Last updatedDec 30, 2021

Condition

Neurocognitive Disorders Alzheimer Disease

Locations shown

CHU Montpellier

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions